Market Technical Analysis: Will the US Stock Market's Rebound Ignite Your Next Trade?
Canada Net Change Percentage Gainers & Losers
Canopy Servicing Appoints Greg Lisiewski to Board
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 23, 2025
Former JCR Capital Founder Announces New Real Estate Venture With Arizona Acquisition
CGC Stockholders With Large Losses Can Lead the Class Action Against Canopy Growth Corporation - Contact Robbins LLP for Information
Investors Who Lost Money on Canopy Growth Corporation(CGC) Should Contact Levi & Korsinsky About Pending Class Action - CGC
Express News | 'Bipartisan Congressional Lawmakers File Bill To End Federal Marijuana Prohibition In Legal States In Line With Trump's Stance' - Marijuana Moment
Tilray's Stock Has Been Below $1 for Months. Here's How It Plans to Fix That.
Retail Buyers vs. Global Sellers: Is Now the Time to Jump into U.S. Stocks?
Trump's Tariff Backtrack: Tech Giants Set to Surge—Is It Time to Buy?
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Canadian Stock Movers for Friday | Seabridge Gold Inc Was the Top Gainer; Gold Led Gains
Cannabis Stock Gainers And Losers From April 8, 2025
BofA Securities Maintains Canopy Growth(CGC.US) With Sell Rating, Cuts Target Price to $0.56
Canopy Growth Price Target Lowered to 80c From 98c at BofA
Insider Trades: Walmart, The Southern Company Among Notable Names This Week
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
Express News | 'Marijuana Rescheduling Isn't On The White House's New List Of Top Drug Policy Priorities Under The Trump Administration' - Marijuana Moment
Canopy Growth Launches Spectrum Reserve, A New Premium Medical Cannabis Brand In Canada